CARGO Therapeutics, Inc. Common Stock (CRGX)
USD 4.01
(-2.32%)
USD 4.01
(-2.32%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -377.19 Million USD | -1804.28% |
| 2022 | 22.13 Million USD | 607.77% |
| 2021 | 3.12 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -53.32 Million USD | 85.86% |
| 2024 Q2 | -125.44 Million USD | -135.26% |
| 2023 Q4 | -377.19 Million USD | -556.52% |
| 2023 FY | -377.19 Million USD | -1804.28% |
| 2023 Q3 | -57.45 Million USD | -47.7% |
| 2023 Q2 | -38.89 Million USD | 0.0% |
| 2022 FY | 22.13 Million USD | 607.77% |
| 2022 Q4 | 22.13 Million USD | 0.0% |
| 2021 FY | 3.12 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -574.278% |
| Alkermes plc | -166.73 Million USD | -126.216% |
| Agenus Inc. | 274.13 Million USD | 237.593% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 120.171% |
| Aptorum Group Limited | 1.35 Million USD | 27895.005% |
| Ardelyx, Inc. | 34.51 Million USD | 1192.927% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 8912.874% |
| Bicycle Therapeutics plc | -481.46 Million USD | 21.658% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 1143.03% |
| ChromaDex Corporation | -24.04 Million USD | -1468.492% |
| Chimerix, Inc. | -25.51 Million USD | -1378.195% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 5513.13% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -1493.069% |
| CRISPR Therapeutics AG | -150.84 Million USD | -150.052% |
| Precision BioSciences, Inc. | -85.41 Million USD | -341.624% |
| Dyadic International, Inc. | -6.37 Million USD | -5813.847% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -2267.357% |
| Fortress Biotech, Inc. | 7.66 Million USD | 5020.952% |
| Lantern Pharma Inc. | -21.7 Million USD | -1637.945% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -241.235% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -4315.114% |
| Incyte Corporation | -3.17 Billion USD | 88.12% |
| IO Biotech, Inc. | -140.69 Million USD | -168.084% |
| Jaguar Health, Inc. | 29.39 Million USD | 1383.355% |
| Novavax, Inc. | -298.29 Million USD | -26.449% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 7167.472% |
| Opthea Limited | 28.15 Million USD | 1439.578% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -2146.656% |
| ContextLogic Inc. | -232 Million USD | -62.582% |
| MiMedx Group, Inc. | -33.9 Million USD | -1012.625% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 3799.765% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -16179.094% |
| NextCure, Inc. | -6.47 Million USD | -5723.545% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -646.898% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -5813.011% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 3201.067% |
| Vaxcyte, Inc. | -368.22 Million USD | -2.434% |
| PDS Biotechnology Corporation | -32.7 Million USD | -1053.175% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 2283.071% |
| Pharming Group N.V. | 109.8 Million USD | 443.513% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -2068.263% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -115.255% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1936.684% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1936.684% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -5212.549% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -6336.706% |
| Acelyrin, Inc. | -216.9 Million USD | -73.898% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -6623.227% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -21778.828% |
| Summit Therapeutics Inc. | 34.67 Million USD | 1187.821% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -5444.48% |
| Senti Biosciences, Inc. | 1.74 Million USD | 21777.644% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -104.321% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -387.006% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -6122.22% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 378164.329% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 60162.261% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -222.259% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -124.207% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 440.21% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -4865.653% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -192.138% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 5570.819% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | -55.631% |
| Immix Biopharma, Inc. | -17.5 Million USD | -2054.172% |
| Keros Therapeutics, Inc. | -316.7 Million USD | -19.099% |
| MEI Pharma, Inc. | -3.7 Million USD | -10080.594% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 3114.875% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 333.205% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 1457.144% |
| Fortress Biotech, Inc. | 7.66 Million USD | 5020.952% |
| Precigen, Inc. | -481 Thousand USD | -78318.087% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 2778.723% |
| AlloVir, Inc. | -62.69 Million USD | -501.657% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -578.23% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 711.668% |
| ImmuCell Corporation | 10.99 Million USD | 3531.954% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -144.697% |
| Onconetix, Inc. | 5.33 Million USD | 7174.847% |
| PureTech Health plc | -167.19 Million USD | -125.597% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -1138.316% |
| Elevation Oncology, Inc. | -19.11 Million USD | -1872.963% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -7583.663% |
| Seer, Inc. | -4.24 Million USD | -8796.014% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -1469.21% |
| Innoviva, Inc. | 255.56 Million USD | 247.592% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -575.195% |
| ESSA Pharma Inc. | -33.62 Million USD | -1021.872% |
| GlycoMimetics, Inc. | -40.98 Million USD | -820.328% |
| GT Biopharma, Inc. | -1.02 Million USD | -36843.291% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -456.468% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 715.752% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -181.32% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -2622.221% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -1206.425% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -500591.587% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -1122.186% |
| Aptose Biosciences Inc. | -8.19 Million USD | -4502.777% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -11954.613% |
| Soligenix, Inc. | -4.95 Million USD | -7517.563% |
| Century Therapeutics, Inc. | 847 Thousand USD | 44632.586% |
| Kura Oncology, Inc. | -20.11 Million USD | -1774.893% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -821.641% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -4391.438% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 20805.497% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -11698.28% |
| Autolus Therapeutics plc | -186.59 Million USD | -102.14% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -665.031% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | -36.765% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 1200.709% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 329.48% |
| GRI Bio, Inc. | -1.79 Million USD | -20925.139% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -4098.921% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -1034.17% |
| IGM Biosciences, Inc. | -72.6 Million USD | -419.504% |
| INmune Bio, Inc. | -25.41 Million USD | -1384.361% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 349.876% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -644.568% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -2221.265% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -12974.547% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 1092.216% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -815.846% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 1282.973% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 199.799% |
| Verastem, Inc. | -37.27 Million USD | -911.833% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -4057.291% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -627.297% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -2392.177% |
| Histogen Inc. | -7.48 Million USD | -4937.946% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -1645.703% |
| Surrozen, Inc. | -32.66 Million USD | -1054.761% |
| Organovo Holdings, Inc. | -1.5 Million USD | -24929.263% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -8873.286% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 2089.382% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 14518.616% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 9175.818% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -4400.468% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -768.263% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -2487.601% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | -19.067% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -52138.18% |
| Apollomics, Inc. | -27.39 Million USD | -1276.861% |
| Amarin Corporation plc | -191.04 Million USD | -97.441% |
| Mesoblast Limited | 55.96 Million USD | 774.001% |
| Turnstone Biologics Corp. | -14.58 Million USD | -2486.334% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -1391.345% |
| Synaptogenix, Inc. | -28.66 Million USD | -1216.02% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -40198.184% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 874.011% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -43653.139% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -5091.121% |
| Exelixis, Inc. | -73.05 Million USD | -416.346% |
| Better Therapeutics, Inc. | -860 Thousand USD | -43759.419% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -1470.778% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | -56.27% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 51344.182% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -4971.043% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 30179.027% |
| Gritstone bio, Inc. | 39.49 Million USD | 1055.156% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -348.498% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -14230.203% |
| Avid Bioservices, Inc. | 169.72 Million USD | 322.233% |
| Insmed Incorporated | 721.62 Million USD | 152.27% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -4026.134% |
| MediWound Ltd. | -5.32 Million USD | -6987.392% |
| OmniAb, Inc. | 9.2 Million USD | 4198.566% |
| Alector, Inc. | -35.63 Million USD | -958.425% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 538.742% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -7554.038% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 2949.09% |
| Zai Lab Limited | -775 Million USD | 51.33% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 210.758% |
| Aura Biosciences, Inc. | -21.52 Million USD | -1652.339% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -357.312% |
| Immunic, Inc. | -45.34 Million USD | -731.917% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -95.218% |
| Veracyte, Inc. | -203.82 Million USD | -85.057% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 159.094% |
| FibroGen, Inc. | 56.76 Million USD | 764.455% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 4335.722% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -13242.061% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -18118.725% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 108.217% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -11189.764% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -127.273% |
| TG Therapeutics, Inc. | 17.86 Million USD | 2211.695% |
| Galecto, Inc. | -21.21 Million USD | -1677.861% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -1485.836% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 124.034% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -1441.317% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -3177.926% |
| XBiotech Inc. | -200.02 Million USD | -88.574% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -348.498% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 8430.19% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -969.651% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -388.475% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 6727.851% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -121.337% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -308.33% |
| Vaxxinity, Inc. | 10.13 Million USD | 3822.769% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 151.23% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -3403.034% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -471.883% |
| NexImmune, Inc. | -3.13 Million USD | -11936.821% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -10824.608% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -2396.061% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -1291.849% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -4102.192% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -302682.26% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -829.683% |
| Ainos, Inc. | 4.07 Million USD | 9349.575% |
| Pluri Inc. | 22.82 Million USD | 1752.245% |
| Prothena Corporation plc | -608.34 Million USD | 37.997% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -217.618% |
| Celularity Inc. | 65.19 Million USD | 678.603% |
| Rallybio Corporation | -24.1 Million USD | -1464.978% |
| Cue Biopharma, Inc. | -33.81 Million USD | -1015.323% |
| MeiraGTx Holdings plc | -40.3 Million USD | -835.911% |
| Omeros Corporation | 331.17 Million USD | 213.894% |
| Humacyte, Inc. | -22.48 Million USD | -1577.448% |
| Immunocore Holdings plc | -358.59 Million USD | -5.186% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -1434.857% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -1120.643% |
| Blueprint Medicines Corporation | 702.83 Million USD | 153.667% |
| CalciMedica, Inc. | -5.53 Million USD | -6720.814% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -100.399% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -3592.882% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -842.106% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -1034.307% |
| Pulmatrix, Inc. | -10.41 Million USD | -3520.918% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -6210.708% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -888.912% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -238.585% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -529.239% |
| Cytokinetics, Incorporated | 642.37 Million USD | 158.718% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -6377.606% |
| Nutriband Inc. | -251.65 Thousand USD | -149782.976% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -1005.516% |
| Vor Biopharma Inc. | 4.3 Million USD | 8871.884% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 93.751% |
| Evogene Ltd. | -19.63 Million USD | -1821.111% |
| ProKidney Corp. | -56.23 Million USD | -570.729% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -674.965% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -3983.397% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 127.655% |
| CorMedix Inc. | -43.05 Million USD | -776.119% |
| BioLineRx Ltd. | 7.33 Million USD | 5241.644% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -1273.352% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 917.368% |
| Atai Life Sciences N.V. | -28.55 Million USD | -1220.789% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 17010.383% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -1553.186% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 2226.817% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -402.426% |
| MediciNova, Inc. | -50.78 Million USD | -642.743% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -378.638% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1676677.062% |
| GeoVax Labs, Inc. | -6.45 Million USD | -5745.576% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -88.764% |
| Biomea Fusion, Inc. | -166.57 Million USD | -126.446% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -110.751% |
| Mereo BioPharma Group plc | -51.46 Million USD | -632.851% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -297.696% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | -28.402% |
| Absci Corporation | -72.59 Million USD | -419.561% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 8360.863% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | -60.892% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -300.368% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -294.155% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -865.349% |
| Allakos Inc. | -24.97 Million USD | -1410.274% |
| Imunon, Inc. | -4.21 Million USD | -8851.216% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -2458.615% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -178.575% |
| BioAtla, Inc. | -109.01 Million USD | -246.012% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 51344.182% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -40069.436% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 3252.19% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -1678.951% |
| XOMA Corporation | -29 Million USD | -1200.659% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -2177.723% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -4083.574% |
| aTyr Pharma, Inc. | -7.44 Million USD | -4963.646% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -202.634% |
| Akero Therapeutics, Inc. | -208.16 Million USD | -81.199% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -361.232% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -306.618% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -43801.074% |
| Akari Therapeutics, Plc | -3.84 Million USD | -9709.909% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 23341.933% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 127.315% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -31646.477% |
| UroGen Pharma Ltd. | 4.39 Million USD | 8690.093% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 432.383% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 524253.025% |
| Orgenesis Inc. | 21.78 Million USD | 1831.505% |
| Entera Bio Ltd. | -10.62 Million USD | -3448.697% |
| GH Research PLC | -78.07 Million USD | -383.101% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -1592.35% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -1314.873% |
| Xencor, Inc. | 29.64 Million USD | 1372.403% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -19048.579% |
| Replimune Group, Inc. | 1.41 Million USD | 26813.244% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -153913.344% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -198.37% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -31646.477% |
| Portage Biotech Inc. | -4.98 Million USD | -7472.596% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1676677.062% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -470.447% |
| OncoCyte Corporation | -6.56 Million USD | -5647.234% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 42130.927% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -8179.644% |
| Purple Biotech Ltd. | -14.13 Million USD | -2567.923% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -1487.772% |
| scPharmaceuticals Inc. | -6.54 Million USD | -5663.04% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -2159.689% |
| HilleVax, Inc. | -165.48 Million USD | -127.931% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -14761.742% |
| Tharimmune, Inc. | -10.93 Million USD | -3349.281% |
| Genprex, Inc. | -6.73 Million USD | -5498.275% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | -2.273% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -326.397% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -26822.984% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -11271.635% |
| OKYO Pharma Limited | -826.84 Thousand USD | -45517.937% |
| Savara Inc. | 153 Thousand USD | 246630.065% |
| Curis, Inc. | -23.88 Million USD | -1479.064% |
| Daré Bioscience, Inc. | -5.15 Million USD | -7212.864% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -48506.336% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -5975.886% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 31930.464% |
| BeiGene, Ltd. | -2.25 Billion USD | 83.259% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 3157.025% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 37.983% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -103.243% |
| Erasca, Inc. | -37.21 Million USD | -913.518% |
| bluebird bio, Inc. | 108.57 Million USD | 447.414% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -29187.449% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 199.589% |
| DBV Technologies S.A. | -126.98 Million USD | -197.034% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -29187.449% |
| Moderna, Inc. | -2.9 Billion USD | 87.025% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -3543.653% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -3370.657% |
| Molecular Templates, Inc. | 707 Thousand USD | 53450.919% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -1102.356% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 208.824% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -359.641% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -311.197% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -1068.787% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -997.251% |
| MacroGenics, Inc. | -66.98 Million USD | -463.098% |
| RenovoRx, Inc. | -1.17 Million USD | -32056.095% |
| Adicet Bio, Inc. | -138.78 Million USD | -171.777% |
| Prime Medicine, Inc. | -27.94 Million USD | -1249.955% |
| Aditxt, Inc. | 18.12 Million USD | 2181.526% |
| Adagene Inc. | -87.62 Million USD | -330.449% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -8955.276% |
| Quantum-Si incorporated | -118.55 Million USD | -218.152% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 1147.607% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -4946.582% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -677.569% |
| SciSparc Ltd. | -2.06 Million USD | -18165.908% |
| Vericel Corporation | 1.27 Million USD | 29637.275% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -3045.434% |
| Minerva Neurosciences, Inc. | 41 Million USD | 1019.883% |
| Generation Bio Co. | 31.44 Million USD | 1299.412% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -115.09% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -1119.775% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 423.511% |
| Invivyd, Inc. | -198.47 Million USD | -90.044% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -317.848% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -15631.445% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -432.831% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -5426.608% |
| 2seventy bio, Inc. | 181.71 Million USD | 307.573% |
| ADMA Biologics, Inc. | 90.06 Million USD | 518.794% |
| Clene Inc. | 3.34 Million USD | 11393.144% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -4052.85% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -1653.48% |
| GeoVax Labs, Inc. | -6.45 Million USD | -5745.576% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | -9.609% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -1350.752% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 312.303% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -9118.742% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 7640.804% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -7141.14% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -189.47% |
| Evaxion Biotech A/S | 5.28 Million USD | 7234.521% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -235.078% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -187.333% |
| Trevena, Inc. | 2.25 Million USD | 16804.65% |
| Surrozen, Inc. | -32.66 Million USD | -1054.761% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -632.268% |
| Cingulate Inc. | 3.08 Million USD | 12335.802% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -12742.731% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 5348.24% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -3959.647% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -375.513% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -186.942% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -257.385% |
| Clearmind Medicine Inc. | -3.94 Million USD | -9466.973% |
| Kronos Bio, Inc. | -36.05 Million USD | -946.184% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 4108.832% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 25968.186% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -595.206% |
| Statera Biopharma, Inc. | 14.41 Million USD | 2716.401% |
| ImmunityBio, Inc. | 618.22 Million USD | 161.012% |
| Korro Bio, Inc. | -132.94 Million USD | -183.724% |
| Kineta, Inc. | -4.54 Million USD | -8206.342% |
| BioVie Inc. | -17.73 Million USD | -2027.135% |
| Codexis, Inc. | -43.27 Million USD | -771.695% |
| Celularity Inc. | 65.19 Million USD | 678.603% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -11802.524% |
| Celcuity Inc. | 6.78 Million USD | 5660.411% |
| Virax Biolabs Group Limited | -3.36 Million USD | -11109.429% |
| Cibus, Inc. | -8.07 Million USD | -4569.361% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -8819.153% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 8353.632% |
| IN8bio, Inc. | -16.38 Million USD | -2201.489% |
| Kodiak Sciences Inc. | -103.87 Million USD | -263.12% |
| Annexon, Inc. | -193.75 Million USD | -94.674% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 1047852.778% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -2055.5% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -10637.005% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 135.777% |
| Eyenovia, Inc. | 1.25 Million USD | 30066.664% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 1501.936% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -11530.928% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -1034.511% |
| Arcellx, Inc. | -296.95 Million USD | -27.018% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -1833.718% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -540.664% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -1719.805% |
| Moolec Science SA | 117.61 Thousand USD | 320797.014% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -882.294% |
| Geron Corporation | 14.76 Million USD | 2655.321% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -894.754% |
| Royalty Pharma plc | 5.65 Billion USD | 106.666% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -166.715% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -5296.596% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -6933.394% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -168.023% |
| Humacyte, Inc. | -22.48 Million USD | -1577.448% |
| Structure Therapeutics Inc. | -124.33 Million USD | -203.357% |
| 89bio, Inc. | -289.05 Million USD | -30.492% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -1394.299% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -21054.851% |
| Genelux Corporation | -6.89 Million USD | -5367.329% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -1114.434% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 551.191% |
| Notable Labs, Ltd. | -9.77 Million USD | -3758.337% |
| Liquidia Corporation | -80.17 Million USD | -370.454% |
| Mustang Bio, Inc. | -3.73 Million USD | -9996.119% |
| Immunovant, Inc. | -635.22 Million USD | 40.621% |
| Quantum-Si incorporated | -118.55 Million USD | -218.152% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -2047.523% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -9004.296% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 4799.028% |
| Acasti Pharma Inc. | -23 Million USD | -1539.604% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -11101.822% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -2221.265% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -173.843% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -12003.568% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -1596.613% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -1931.294% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -122.823% |
| PepGen Inc. | -60.67 Million USD | -521.709% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -1541.674% |
| United Therapeutics Corporation | -507.7 Million USD | 25.706% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -1872.137% |
| Solid Biosciences Inc. | -47.75 Million USD | -689.929% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -43653.139% |
| Immuneering Corporation | -54.94 Million USD | -586.515% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -8873.286% |
| Silo Pharma, Inc. | -3.52 Million USD | -10602.555% |
| Belite Bio, Inc | -87.27 Million USD | -332.207% |
| XOMA Corporation | -29 Million USD | -1200.659% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -433.532% |
| Bionomics Limited | 227 Million USD | 266.156% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -224.376% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -14791.078% |
| uniQure N.V. | -102.95 Million USD | -266.379% |
| Cassava Sciences, Inc. | -121.13 Million USD | -211.378% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -8955.276% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 1021.079% |
| Forte Biosciences, Inc. | -11.96 Million USD | -3053.507% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -12090.259% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 355940.566% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -11530.928% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 4335.722% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -4986.179% |
| Altimmune, Inc. | -134.48 Million USD | -180.467% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 290.438% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -14791.078% |
| Compugen Ltd. | -12.9 Million USD | -2823.055% |
| Peak Bio, Inc. | 10.34 Million USD | 3747.826% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -133183.039% |
| Benitec Biopharma Inc. | -50.58 Million USD | -645.702% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -261.509% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 2020.036% |
| Zura Bio Limited | -99.8 Million USD | -277.924% |
| PolyPid Ltd. | 6.17 Million USD | 6213.306% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 608.892% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 2020.036% |
| Instil Bio, Inc. | 75.35 Million USD | 600.532% |
| argenx SE | -2.02 Billion USD | 81.409% |
| Immunome, Inc. | -97.02 Million USD | -288.74% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -1576.777% |
| Verona Pharma plc | -220.44 Million USD | -71.106% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -425.753% |
| Shattuck Labs, Inc. | -121.42 Million USD | -210.64% |
| CervoMed Inc. | -7.79 Million USD | -4740.221% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -103.339% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -8525.452% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -186.315% |
| Moolec Science SA | 117.61 Thousand USD | 320797.014% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -16385.786% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 2472.512% |
| AnaptysBio, Inc. | -18.15 Million USD | -1978.073% |
| Design Therapeutics, Inc. | -18.15 Million USD | -1978.187% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -435.927% |
| NeurAxis, Inc. | 145.7 Thousand USD | 258981.949% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 3458.182% |
| Lumos Pharma, Inc. | -28.49 Million USD | -1223.802% |
| Achilles Therapeutics plc | -126.92 Million USD | -197.179% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -425.753% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -57422.303% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -1715.703% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 25968.186% |
| Nutriband Inc. | -251.65 Thousand USD | -149782.976% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -2763.799% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -4969.772% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 210.874% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 1689.176% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 15.706% |
| Palisade Bio, Inc. | -12.06 Million USD | -3026.842% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -168.825% |
| Beam Therapeutics Inc. | -262.72 Million USD | -43.57% |
| Neurogene Inc. | -131.95 Million USD | -185.848% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 1828.965% |
| AEON Biopharma, Inc. | -4.88 Million USD | -7629.324% |
| Sesen Bio, Inc. | -112.55 Million USD | -235.123% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -277.72% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -15965.769% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -866.512% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -352.908% |
| Athira Pharma, Inc. | -88.99 Million USD | -323.815% |
| Vaccinex, Inc. | -1.28 Million USD | -29185.016% |
| HCW Biologics Inc. | 2.85 Million USD | 13303.843% |
| XOMA Corporation | -29 Million USD | -1200.659% |
| Nektar Therapeutics | 210.24 Million USD | 279.41% |
| Arvinas, Inc. | -313.8 Million USD | -20.201% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 23341.933% |
| Merus N.V. | -192.88 Million USD | -95.553% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 728.809% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -5336.596% |
| Rezolute, Inc. | -68.16 Million USD | -453.326% |
| Clene Inc. | 3.34 Million USD | 11393.144% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -2760.325% |
| BeyondSpring Inc. | -13.75 Million USD | -2642.21% |
| Synlogic, Inc. | -6.68 Million USD | -5542.349% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 33361.993% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -4361.159% |
| Peak Bio, Inc. | 10.34 Million USD | 3747.826% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -357.645% |
| Krystal Biotech, Inc. | -350.23 Million USD | -7.697% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 403.88% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -123.195% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -11847.222% |
| MannKind Corporation | 143.89 Million USD | 362.122% |
| Ikena Oncology, Inc. | -109.15 Million USD | -245.552% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -4882.05% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -1039.55% |
| Gossamer Bio, Inc. | 180.35 Million USD | 309.138% |
| CohBar, Inc. | -5.93 Million USD | -6259.941% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -1167.954% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 8360.863% |
| Legend Biotech Corporation | -949.39 Million USD | 60.271% |
| Mural Oncology plc | -255.84 Million USD | -47.431% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 1270.855% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -7907.21% |
| Disc Medicine, Inc. | -358.28 Million USD | -5.278% |
| Champions Oncology, Inc. | 4.81 Million USD | 7938.549% |
| REGENXBIO Inc. | 54.76 Million USD | 788.707% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -140168.197% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -149.756% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -4085.428% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -367.497% |
| Vaxart, Inc. | -8.24 Million USD | -4477.005% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -651.676% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -196.614% |
| Cellectis S.A. | -43.85 Million USD | -760.087% |
| Longeveron Inc. | -2.9 Million USD | -12870.805% |
| Repare Therapeutics Inc. | -107.85 Million USD | -249.711% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 138.951% |
| Inozyme Pharma, Inc. | 12 Million USD | 3242.211% |
| Revolution Medicines, Inc. | -608.2 Million USD | 37.983% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -30565.935% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | -42.273% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -151.34% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -2310.628% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -50871.757% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 96.056% |
| Denali Therapeutics Inc. | -74.86 Million USD | -403.828% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -3045.434% |
| Veru Inc. | 4.77 Million USD | 7991.076% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -3254.001% |
| Cingulate Inc. | 3.08 Million USD | 12335.802% |
| Passage Bio, Inc. | 4.58 Million USD | 8326.63% |
| Context Therapeutics Inc. | -14.44 Million USD | -2510.35% |
| Exicure, Inc. | 5.84 Million USD | 6548.812% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | -63.728% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -853.225% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 2503.868% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -541.252% |
| Nuvalent, Inc. | -335.38 Million USD | -12.464% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 21848.376% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -406.419% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -4142.868% |
| OmniAb, Inc. | 9.2 Million USD | 4198.566% |
| Anew Medical, Inc. | 1.43 Million USD | 26431.603% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 2402.507% |
| Lipocine Inc. | -4.75 Million USD | -7833.194% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -243.438% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 2576.469% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -644.568% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 1615.31% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -5512.126% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -473.003% |
| Ocugen, Inc. | -32.52 Million USD | -1059.838% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -340.772% |
| Q32 Bio Inc. | -37.94 Million USD | -893.968% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -59962.261% |
| Alumis Inc. Common Stock | -13.52 Million USD | -2688.018% |
| Equillium, Inc. | -22.39 Million USD | -1584.49% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -1375.246% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -1056.078% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -152045.292% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 381.398% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 11894.59% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 114942.848% |
| Dominari Holdings Inc. | 195 Thousand USD | 193531.282% |
| Edesa Biotech, Inc. | -5.26 Million USD | -7061.524% |
| vTv Therapeutics Inc. | -8.91 Million USD | -4130.021% |
| Bio-Techne Corporation | 267.74 Million USD | 240.876% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -2227.047% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -219.399% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -4388.766% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -2881.511% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | -53.881% |
| Nkarta, Inc. | 57.29 Million USD | 758.285% |
| BioCardia, Inc. | 212 Thousand USD | 178020.283% |
| Iterum Therapeutics plc | 13.43 Million USD | 2906.898% |